Bookrunners JPMorgan, Barclays, Piper Jaffray assist with financing
By Devika Patel
Knoxville, Tenn., Aug. 6 – Imprivata, Inc. priced a $64.39 million secondary sale of stock with a $9.66 million greenshoe on Aug. 5, according to a prospectus supplement and 8-K filed Thursday with the Securities and Exchange Commission.
The company will sell 4,566,666 common shares at $14.10 apiece. The price per share is a 9.85% discount to the Aug. 4 closing share price of $15.64.
J.P. Morgan Securities LLC, Barclays and Piper Jaffray & Co. are the bookrunning managers.
Settlement is expected Aug. 11.
The provider of authentication and access management solutions for the health-care industry is based in Lexington, Mass.
| Issuer: | Imprivata, Inc.
|
| Issue: | Common shares
|
| Amount: | $64,389,991
|
| Greenshoe: | $9,658,486, or 684,999 shares
|
| Shares: | 4,566,666
|
| Price: | $14.10
|
| Warrants: | No
|
| Bookrunners: | J.P. Morgan Securities LLC, Barclays and Piper Jaffray & Co.
|
| Lead manager: | Stifel
|
| Co-managers: | Wells Fargo Securities and Oppenheimer & Co.
|
| Announcement date: | Aug. 3
|
| Pricing date: | Aug. 5
|
| Settlement date: | Aug. 11
|
| Stock symbol: | NYSE: IMPR
|
| Stock price: | $15.64 at close Aug. 4
|
| Market capitalization: | $379.55 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
